Julien Fleurence PhD, PharmD

September 5, 2019

Dr. Fleurence is a researcher pharmacist at Baylor College of Medicine. Under the mentorship of  Dr. Andras Heczey, a past Powered by Pablove grantee, he is exploring new therapy for pediatric liver cancer using the body’s own immune system.  In Dr. Fleurence’s own words:  Hepatoblastoma and hepatocellular carcinoma are the most common liver cancers in […]

Read More

Grant Rowe, MD PhD

September 5, 2019

A physician scientist at Children’s Hospital Boston, Dr. Grant Rowe is a very busy man! He sees patients and works in a lab. Dr. Rowe is studying leukemia in infants, which is often a very aggressive disease. His Powered by Pablove research project hopes to illuminate how this disease develops and grows so that new […]

Read More

Laura Perin, PhD

September 5, 2019

A scientific researcher at CHLA, Dr. Laura Perin is using cutting-edge methods to study kidney development.  With her Powered by Pablove research grant, she hopes to improve our understanding of how kidney tumors develop in children. In Dr. Perin’s own words: Wilms Tumor (WT), a pediatric cancer known as nephroblastoma, accounts for 95% of the […]

Read More

Surinder Kumar, PhD

September 5, 2019

Dr. Kumar is a research investigator at the University of Michigan studying the proteins on Ewing’s sarcoma cells. The objective of his Powered by Pablove research grant is to identify targets for less toxic and more effective treatment options for this aggressive bone tumor. In Dr. Kumar’s own words: With the generous support of the […]

Read More

Kathryn Lemberg, md, phd

October 11, 2018

Dr. Lemberg is a pediatric oncologist and lab researcher at John’s Hopkins University School of Medicine. She just received her second year of funding from Pablove to continue researching a novel therapy for Malignant Peripheral Nerve Sheath Tumors. Her project focuses on a novel agent developed at John’s Hopkins that works differently than conventional chemotherapy, […]

Read More